Every day you’re challenged to deliver faster, reliable results to inform clinicians. Now the power of LC-MS/MS technology is available with the Topaz™ System from SCIEX, developed with the demanding clinical lab in mind. It is the first FDA-reviewed integrated LC-MS/MS IVD system, that is open by design and closed when you need it.
Siemens Healthineers has appointed Dr. Deepak Nath as President of Laboratory Diagnostics effective February 1. Nath succeeds Franz Walt, who served from 2014-2017, and led the business during its launch of the Atellica Solution. Nath will continue the endeavor to transform care delivery in the laboratory by growing the business, leveraging his extensive operational experience in healthcare. He…
HORIBA UK Ltd, Medical announces that Thame and Marlow Community Hubs, within Buckinghamshire Healthcare NHS Trust, have each recently installed HORIBA Medical’s latest point-of-care testing analyser, the Microsemi CRP. These new analysers are now streamlining existing diagnostic pathways in the community and helping to reduce local A&E admissions for frail patients. The Microsemi CRP is a…
SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced the launch of the Citrine Triple Quad MS/MS and Citrine QTRAP MS/MS systems for clinical diagnostics. The Citrine system is designed specifically to meet the unique needs of clinical labs that require maximum sensitivity, the highest throughput, a wide…
Move over, lab-on-a-chip and lab-on-paper. There’s a new diagnostic technology in research labs that is gaining credibility. It is called lab-on-skin technology and some scientists are quite excited about how it might be used for a variety of clinical purposes. A recent story published in ACS Nano titled, “Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health…
Lawrence Livermore National Laboratory scientists and engineers have developed a “brain-on-a-chip” device aimed at testing and predicting the effects of biological and chemical agents, disease, or pharmaceutical drugs on the brain over time without the need for human or animal subjects. The device, part of the Lab’s iCHIP (in-vitro Chip-Based Human Investigational Platform) project,…
Professor Jo Martin, the newly-appointed President of the Royal College of Pathologists in the United Kingdom, believes the National Health Service (NHS) is on the brink of embracing digital pathology more widely. A number of UK laboratories, he explained, are adopting digital pathology in histopathology – in line with some labs in Sweden and Holland, where it has become routine – and the…
Up to the early 16th century, essentially medical diagnostics was limited to uroscopy – the observation of a urine sample in a uroscopy flask with a candle providing light. In a visual examination the doctor would determine the colour of the urine as well as cloudiness and precipitates, followed by a smell and taste test. The information he gathered provided the basis of his diagnosis. 100…
A new genetic test to assess breast cancer risk in women who have a family history of the disease could be introduced into clinical practice in the UK within the next few months. Devised at Manchester University NHS Foundation Trust (MFT) and the University of Manchester, researchers believe the test for high-risk groups could also help reduce the number of women needing to have surgery to remove…
Bio-Rad Laboratories announces the launch of the "QXDx BCR-ABL %IS" Kit, the first CE-IVD digital PCR test that can monitor the molecular response of patients with chronic myeloid leukemia (CML) to therapy.
Agena Bioscience, a global provider of molecular genetic solutions, announced it has been selected to participate as an innovative technology provider in the ‘Liquid biopsies and IMAging for improved cancer care’ (LIMA) project. The LIMA project has been awarded a EUR 6.3 million Horizon 2020 European Union research grant to develop an integrated approach for personalized cancer treatment.…
Facilitating precise sample documentation and audience engagement, Olympus’ 18 megapixel SC180 camera shows unprecedented detail, especially at low magnifications. The easy-to-use and cost-effective SC180 camera reinforces Olympus’ commitment to making 4K Microscopy the new standard.
Gold nanoparticles could help make drugs act more quickly and effectively, according to new research conducted at Binghamton University, State University of New York. Nanoparticles are microscopic particles that are bigger than atoms but smaller than what the eye can see. They are unique for their large surface area-to-volume ratio and their fairly ubiquitous nature. A new study, co-conducted by…
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published in Cell Host and Microbe, a scientific team led by the University of Wisconsin–Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts. Conducting a sweeping analysis of everything from enzymes to lipids to immune-system-associated molecules,…
DNAe, the inventor of semiconductor-based genomic analysis technologies, and the developer of a new, game-changing test for bloodstream infections that can lead to sepsis announced new data on its test for bloodstream infections, LiDia BSI. The data demonstrates the ability of the LiDia BSI closed cartridge-based test to rapidly identify low levels of bacterial and fungal pathogens and resistance…
EKF Diagnostics, the global in vitro diagnostics company, introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer. At Medica 2017 on Stand H3/C70, EKF will be highlighting how DiaSpect Tm is the only reagent-free hemoglobin analyzer with mobile connectivity. Lightweight and palm-sized, the DiaSpect Tm analyzer delivers laboratory quality…
The capillary blood collection system not only benefits geriatric patients, or those who need regular blood sampling, but also burns victims and others, including the youngest patients. All need a gentle approach. To that end, Austrian firm Greiner Bio-One has developed and optimised its MiniCollect system.
Just two decades ago, even though promising, point-of-care testing (POCT) was only used in hospitals and surgeries by a small number of specialists. Today POCT is in use throughout healthcare.
Providing insights into new cardiac testing methods, Professor Stefan Holdenrieder, Director of the Institute of Laboratory Medicine at Munich’s German Heart Centre, explained why biomarkers are a game changer in diagnostics.
A Swiss hospital group is using drones to fly medical laboratory specimens between its key centres. In what is believed to be a world first, the eight-hospital Ticino EOC organisation has partnered with Swiss Post and US drone manufacturer Matternet to spearhead faster, more efficient specimens transport.
BBI Solutions (BBI), immunoassay developer and reagent supplier, acquired Maine Biotechnology Services Inc. (MBS) in July 2017, adding antibody development to the firm’s end to end assay development services. This also strengthens BBI’s reagents antibodies portfolio, providing a wide range of high quality biomarkers for infectious disease.
A new blood test to detect heart attacks has been developed by a team of researchers at King’s College, London, which could speed up diagnosis, according to results from pan-European trials. The test is quicker than the standard test, which combines an ECG with a blood test to measure the levels of troponin. Under current guidelines, suspected heart attack cases are tested for high blood…
Not long ago, POCT was a specialist diagnostic discipline used by only few laboratory staff. This has changed considerably over recent years. Initially, the main focus had been on determining electrolytes, blood gases, blood clotting and blood count, but further parameters, such as kidney function, cardiac enzymes, urine tests and testing for autoimmune diseases have now been added. Whilst the…
For POCT, point-of-care testing, a lab has to purchase new equipment, perform new measurements and handle new parameters – right? Right! However, more importantly, POCT requires the adaptation and integration of the existing lab organisation, with all its consequences, from additional quality control down to new areas of responsibility. Dr Herbert Stekel is currently integrating three…
Useful IT tools are abundant in today’s laboratories – ranging from software to evaluate analyses to specialist software for quality control, and middleware linking different devices. However, all these tools generate data, the adequate utilisation of which is not an easy task, said Udo Margraff, CEO of Laboratoires Réunis in Luxembourg, during our European Hospital interview. Among other…